88 results
Page 2 of 5
8-K
EX-1.1
wq8ccriin1
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
S-3
EX-1.2
lfg nhi29ff1z8r1
1 Jul 22
Shelf registration
4:13pm
S-3
EX-4.6
0ir43qtjpfeb vtyv
1 Jul 22
Shelf registration
4:13pm
S-3
EX-4.7
3scxz
1 Jul 22
Shelf registration
4:13pm
DEF 14A
bwy6zxzu
28 Apr 22
Definitive proxy
8:36am
424B3
2qdshlgb 124p6
31 Mar 22
Prospectus supplement
11:42am
POS AM
g2pmee1
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
EX-10.2
o2jyazrn akkfv9hnud
10 Dec 21
Prospectus supplement
8:24am
424B3
EX-10.1
b4w 4a2idvj
10 Dec 21
Prospectus supplement
8:24am
424B3
EX-10.3
p3nr2yvivr8ym46b
10 Dec 21
Prospectus supplement
8:24am
8-K
EX-10.2
mvvrstet
10 Dec 21
Departure of Directors or Certain Officers
8:17am
8-K
EX-10.3
zbj9i
10 Dec 21
Departure of Directors or Certain Officers
8:17am
8-K
EX-10.1
fxvg2t7l05ar t162y0
10 Dec 21
Departure of Directors or Certain Officers
8:17am
424B3
hb2g7cf zc7auaf
5 Aug 21
Prospectus supplement
4:26pm
8-K
5g29 90lfxg5ljn
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.5
ltcq7i9oqdxhd
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.3
4s9l hk2dk1
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am